Press Release

Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – November 16, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers

LYON, France--(BUSINESS WIRE)--Nov. 16, 2017--

Regulatory News:

Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP):

Listing markets:

Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) &

Nasdaq Global Select Market in the United-States (Symbol : ERYP)

Website : www.erytech.com

Date  

Total of shares composing

the share capital

 

Total of brut(1) voting

rights

 

Total of net(2) voting

rights

January 31, 2017   8 732 648   10 410 050   10 407 550
February 28, 2017   8 732 648   10 395 830   10 393 330
March 31, 2017   8 734 698   10 351 950   10 349 450
April 19, 2017   11 740 648(3)   13 303 800(3)   13 301 300(3)
April 30, 2017   11 743 148   13 303 549   13 301 049
May 31, 2017   11 744 148   13 304 550   13 302 050
June 30, 2017   11 744 448   13 298 756   13 296 256
July 31, 2017   11 744 448   13 300 266   13 297 766
August 31,2017   11 744 448   13 301 546   13 299 046
September 30, 2017   11 745 648   13 300 046   13 297 546
October 31, 2017   11 754 422   13 304 770   13 302 270
November 16, 2017   17 934 559(4)   19 484 907(4)   19 482 407(4)
     

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The number of shares and voting rights raised following the issuance of 3 000 000 new shares (cf. Note d’opération Visa n°17-161 available on the Company’s website)
(4) The numbers of shares and voting rights raised following the issuance of 5 374 033 new shares on November 10, 2017 and of 806 104 new shares expected to be issued on November 16, 2017 (cf. Note d’opération Visa n°17-584 available on the Company’s website).

Source: Erytech Pharma

Erytech Pharma